IPO TABLES: Third quarter update, plus three companies price offerings, one sets terms, one files and two postpone
This article was originally published in Scrip
Executive Summary
There were 26 initial public offerings by health care companies in the US during the third quarter of 2014, including 19 biotechnology firms, but returns from those offerings were mixed, according to the IPO-tracking firm Renaissance Capital.